Skip to content

Quality and analytical methods

Write a useful elemental-contaminant specification for a mineral ingredient

Define analytes, units, reporting limits and matrix suitability when reviewing heavy-metal results for magnesium glycinate.

By MagneINNOUpdated 3 min read

The practical answer

A useful elemental-contaminant specification identifies the analytes, acceptance limits, reporting units, method and relevant detection capability. Evaluate the ingredient’s contribution at the intended use level. A single “heavy metals: passes” statement cannot resolve every contaminant or finished-product requirement.

Specify the question rather than the instrument

Start by identifying which elements matter for the ingredient, process, finished product and destination market. Do not copy another product’s limits without understanding its use level and regulatory context. Ask whether a reported result concerns a total element or a particular chemical species; those measurements are not interchangeable.

The FDA Elemental Analysis Manual includes methods with different analytical scopes, including total-element and speciation work. It is a useful source for understanding those distinctions, not a universal release specification for magnesium glycinate. [1] An instrument label such as ICP-MS does not establish which species or concentration range was reliably measured.

Calculate the ingredient contribution

For mass-based results, 1 mg/kg equals 1 microgram per gram. In an illustrative formula, an ingredient containing 0.20 mg/kg of an element contributes 0.30 micrograms when 1.5 g of that ingredient is used. This is concentration multiplied by input mass, not an acceptance limit or a safety conclusion.

Repeat that calculation for other contributing ingredients and the actual intended serving pattern. Keep the arithmetic separate from the qualified assessment of applicable limits, exposure and label requirements. A raw-material specification and a finished-product decision can use different quantities and must not be compared as though both were simply parts per million.

Specification fieldUseful detail
AnalyteName and, where relevant, chemical species
LimitNumerical criterion with units and basis
Reporting capabilityLimit of quantitation or reporting limit appropriate to the criterion
MethodIdentifier, revision, preparation and matrix suitability
ResultActual value or qualified less-than result, linked to the lot

On smaller screens, scroll the table horizontally.

Check the method in the mineral matrix

FDA EAM 4.7 describes an ICP-MS method for elements in food and discusses its scope and matrix limitations. Its existence should not be presented as automatic validation for every mineral supplement or raw material. The laboratory must establish suitability for the actual assignment. [2]

  • Ask how the laboratory addresses a high mineral concentration, dilution and potential matrix or spectral interference.
  • Confirm that blanks, recovery checks and other quality controls support the intended reporting level.
  • Read a less-than result alongside its reporting limit. “Not detected” is not the same as zero.
  • Confirm that the method’s validation or verification covers the material and concentration range actually submitted.

Turn the review into a release decision

Resolve an inadequate reporting limit before accepting a pass statement. If a result approaches an internal criterion, have the responsible quality team consider the method’s uncertainty and established decision rule rather than rounding the value into compliance.

Retain the agreed method, limit rationale and formulation contribution calculation together. This article supplies a purchasing and laboratory discussion framework; it does not establish a universal contaminant limit, certify regulatory compliance or claim that any particular supplier lot meets a standard.

Sources & further reading

  1. FDA: Elemental Analysis Manual for Food and Related Products
  2. FDA EAM 4.7: ICP-MS determination of elements in food, version 1.3
This guide supports ingredient qualification and formulation planning. It does not establish a clinical dose, certify a finished product, or replace current lot documentation. General references explain the underlying topic; they do not independently verify MagneINNO-specific performance claims.